Skip to main content
. 2019 Feb 26;9:2749. doi: 10.1038/s41598-019-39067-8

Figure 5.

Figure 5

S100A8 and S100A9 transcripts are diagnostic and poor prognostic markers for GBM. (A) ROC curve depicting transcript levels of S100A8 and S100A9 discriminate between control and GBM, AUC and p value is indicated. (B) ROC curve depicting transcript levels of S100A8 and S100A9 discriminate between grade III and GBM, AUC and p value is indicated. (C) ROC curve depicting transcript levels of S100A8 and S100A9 discriminate mesenchymal subtype from other GBM subtypes, AUC and p value is indicated. (D) Univariate and Multivariate cox proportional hazard regression analysis was performed using TCGA Affymetrix data for transcript levels of S100A8 and S100A9 along with age, G-CIMP status, IDH1 mutation status, MGMT promoter methylation status. (E,F) Kaplan Meier survival analysis using TCGA Affymetrix cohort (n = 518) for transcript levels of S100A8 and S100A9. Log-rank (Mantel–Cox) test was applied and the p value is indicated.